Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity - PubMed
In patients with heart failure with preserved ejection fraction and obesity, treatment with semaglutide (2.4 mg) led to larger reductions in symptoms and physical limitations, greater improvements in...
pubmed.ncbi.nlm.nih.gov